Patent details

Basic Information

Publication number:

EP1289992

PCT Application Number:

PCT/SE/2001/001239

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP019371095

PCT Publication Number:

WO/2001/092262

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NEW CRYSTALLINE FORM OF A TRIAZOLO(4,5-D)PYRIMIDINE COMPOUND

French Title of Invention:

NOUVELLE FORME CRISTALLINE D'UN COMPOSE DE TRIAZOLO(4,5-D)PYRIMIDINE

German Title of Invention:

NEUE KRISTALLINE FORM EINER TRIAZOLO(4,5-D)PYRIMIDIN-VERBINDUNG

SPC Number:

Dates

Filing date:

31/05/2001

Grant date:

15/03/2006

EP Publication Date:

15/03/2006

PCT Publication Date:

06/12/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/03/2003

EP B1 Publication Date:

15/03/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

31/05/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/05/2001

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

Name:

VAN MALDEREN MICHEL

From:

15/06/2006

Address:

ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)

To:

Inventor

1

Name:

COSGROVE Steve, AstraZeneca R & D Charnwood

Address:

United Kingdom (GB)

2

Name:

LASSEN Bo

Address:

Sweden (SE)

3

Name:

BOHLIN Martin

Address:

Sweden (SE)

Priority

Priority Number:

0013407

Priority Date:

02/06/2000

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 487/04;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

11/05/2020

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages